Avance Clinical Contracted for Atossa Therapeutics AT-301 Nasal Spray Clinical Study, Atossa’s Second COVID-19 Therapeutic Development Program
Adelaide, AUS, July 22, 2020 – (ACN Newswire) – The leading Australian CRO for biotechs and Frost & Sullivan 2020
Read More